Acute coronary syndrome: initial assessment and management
Overview
•AV node supplied by posterior interventricular artery - branch of the right coronary artery (RCA) in ~85% (right-dominant circulation)
•RCA occlusion → infarction of AV node → complete heart block - classic complication of inferior STEMI
Presentation
•Central crushing chest pain ± radiation to jaw/left arm; diaphoresis, nausea, dyspnoea
•Complete heart block (inferior MI/RCA) - chest pain + bradycardia (~40 bpm) + haemodynamic compromise (hypotension)
•Unstable presentation - signs of shock (hypotension, tachycardia), reduced consciousness, heart failure → requires immediate electrical intervention
Investigations
🥇 First-line
•12-lead ECG - ST elevation, new LBBB, ST depression, T-wave changes, heart block
•High-sensitivity troponin - serial at 0 h and 1-3 h; rise/fall confirms necrosis (NSTEMI); normal in unstable angina
•Continuous cardiac monitoring - detects VF, complete heart block
🏆 Gold standard
•Coronary angiography - defines occlusion, guides PCI/CABG
Management
•Oxygen only if SpO2 <94% (target 94-98%; 88-92% in COPD) - routine O2 in normoxic patients not beneficial
•Aspirin 300 mg orally (loading dose) unless allergy
•Sublingual GTN for pain - withhold if SBP <90 mmHg
Complications
•Complete heart block - inferior MI (RCA occlusion); bradycardia + haemodynamic compromise
•VF - most common cause of early death post-MI
•New pan-systolic murmur 2-5 days post-MI:
•Papillary muscle rupture → acute mitral regurgitation (posterior wall MI, RCA)
•Ventricular septal rupture → left-to-right shunt (anterior MI, LAD)
•Both cause acute haemodynamic collapse - require urgent surgical/catheter intervention
Unstable tachycardia / cardiac arrest management
•Unstable tachycardia (shock, heart failure, syncope, reduced consciousness) → synchronised DC cardioversion - can be repeated up to 3 times
•Non-shockable cardiac arrest (asystole/PEA) → CPR 30:2 + IV adrenaline 1 mg = 10 ml of 1 in 10,000 solution IV
•Shockable arrest (pulseless VT/VF) → unsynchronised defibrillation
Follow-up / secondary prevention
•Aspirin 75 mg once daily indefinitely
•Second antiplatelet - ticagrelor 90 mg twice daily or clopidogrel 75 mg once daily for 12 months (DAPT)
•Atorvastatin 80 mg once daily - high-intensity statin
•ACE inhibitor (e.g. ramipril) - reduces afterload, attenuates LV remodelling
•Beta-blocker (e.g. bisoprolol) - for at least 12 months post-MI
•Second-line: Aldosterone antagonist (e.g. eplerenone 50 mg once daily) - if heart failure or LVEF ≤40%; monitor potassium